Results 91 to 100 of about 820 (178)

Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo [b]thiophene derivatives as gut-selective NaPi2b inhibitors

open access: green, 2022
Yasunobu Ushiki   +15 more
openalex   +1 more source

2024 ACVIM Forum Research Abstract Program

open access: yes
Journal of Veterinary Internal Medicine, Volume 38, Issue 5, Page 2840-2970, September/October 2024.
wiley   +1 more source

Supplementary Data (for Review only) from The Dolaflexin-based Antibody–Drug Conjugate XMT-1536 Targets the Solid Tumor Lineage Antigen SLC34A2/NaPi2b

open access: gold, 2023
Natalya D. Bodyak   +23 more
openalex   +1 more source

Konjugat Antibodi-Obat sebagai Pendekatan Pengobatan Alternatif untuk Kanker Paru Bukan Sel Kecil (NSCLC) di Tengah Peningkatan Resistensi Terapi: Tinjauan Sistematis [PDF]

open access: yes
Kanker paru bukan sel kecil atau non-small cell lung cancer (NSCLC) adalah jenis kanker paru yang paling umum dan memiliki tantangan signifikan dalam pengobatan, terutama terkait dengan resistensi terhadap terapi yang ditargetkan.
Kasasiah, Ahsanal   +1 more
core   +1 more source

Screening of factors inducing alveolar type 1 epithelial cells using human pluripotent stem cells. [PDF]

open access: yes
ヒトiPS細胞由来肺胞スフェロイドの"on-gel培養法"による化合物スクリーニング --I型肺胞上皮細胞の分化を促進するシグナル経路を同定--. 京都大学プレスリリース. 2024-03-29.Constructing "on-gel" alveolar organoids as a new screening platform. 京都大学プレスリリース.
Gotoh, Shimpei   +6 more
core   +1 more source

26P Structurally constrained tumor-specific epitope within the largest extracellular domain of sodium-dependent phosphate transporter NaPi2b [PDF]

open access: yesAnnals of Oncology, 2021
L.F. Bulatova   +7 more
openaire   +1 more source

Supplementary Figure 1 from Phase Ia Study of Anti-NaPi2b Antibody–Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non–Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer [PDF]

open access: gold, 2023
David E. Gerber   +26 more
openalex   +1 more source

Supplementary Figure 1 from TUB-040, a Homogeneous and Hydrophilic NaPi2b-Targeting ADC with Stably Linked Exatecan, Exhibits Long-lasting Antitumor Activity and a Well-Tolerated Safety Profile [PDF]

open access: gold
Annette M. Vogl   +19 more
openalex   +1 more source

Home - About - Disclaimer - Privacy